CD274 and neoplasm: However, within the tumor microenvironment, CD274 expressed on tumor cells engages CD279 on immune cells, leading to phosphorylation of immunoreceptor tyrosine motifs, recruitment of SHP1/2, and inhibition of ZAP70 and PI3K signaling.